5FU Continuous Infusion in Heavily Pretreated Advanced Breast Cancer Patients

Publisher： Karger

E-ISSN： 2296-5262|34|12|696-700

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.34, Iss.12, 2011-11, pp. : 696-700

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Continuous Infusion of Oxaliplatin plus Chronomodulated Capecitabine in 5-Fluorouracil- and Irinotecan-Resistant Advanced Colorectal Cancer Patients

By  

Oncology, Vol. 69, Iss. 1, 2005-09 ,pp. : 27-34

Karger

Access to resources Recommend Favorite

5-Fluorouracil: Synchronous Application of Continuous and Bolus Therapy in Heavily Pretreated Metastatic Colorectal Cancer: A Phase I/II Study

By  

Oncology Research and Treatment, Vol. 23, Iss. 2, 2000-05 ,pp. : 128-132

Karger

Access to resources Recommend Favorite

A Phase II Feasibility Study of Weekly Paclitaxel in Heavily Pretreated Advanced Gastric Cancer Patients with Poor Performance Status

By  

Oncology, Vol. 77, Iss. 6, 2009-12 ,pp. : 349-357

Karger

Access to resources Recommend Favorite

The Role of 5-Fluorouracil (5-FU) Reintroduction with Irinotecan or Oxaliplatin in Truly 5-FU-Refractory Advanced Colorectal Cancer Patients

By  

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 212-216

Karger

Access to resources Recommend Favorite

Salvage Chemotherapy with Gemcitabine and Oxaliplatin in Heavily Pretreated Patients with Metastatic Breast Cancer: A Multicenter Phase II Study

By  

Oncology, Vol. 70, Iss. 4, 2006-10 ,pp. : 273-279

Karger

Access to resources Recommend Favorite